These psychedelics may soon be “legal”
While both MDMA and psilocybin show promise for hard-to-treat psychiatric disorders, it’s important to keep in mind that the conditions in these studies were strictly controlled and the patients meticulously monitored during treatment. Once approved, MAPS says the drug will be administered in an inpatient setting at DEA-certified clinics by licensed therapists who have been…
Recent Comments